Dr. Young’s publications and presentations on chronic fatigue syndrome
Scientific Reviewer, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Panel for Department of Defense’s Congressionally Directed Medical Research Programs, May 2023 - present.
Chair, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (CT-ME/CFS) Peer Review Panel, Peer Reviewed Medical Research Program (PRMRP) for the Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP), October 2021.
Chronic fatigue syndrome: 3 cases and a discussion of the natural history of attention-deficit/hyperactivity disorder. Postgraduate Medicine, January 2013.
“Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: A double-blind, placebo-controlled study.” Psychiatry Research, October 2012.
Poster presentation at 2012 American Psychiatric Association Conference, May 7, 2012. Poster #34399.
“ADHD is a notable characteristic of patients suffering from chronic Lyme disease: a survey of adults at the Michigan Lyme Disease Association Conference.” Poster presentation at 2011 U.S. Psych and Mental Health Congress, November 8, 2011. Poster # 111.
Poster presentation at 2011 U.S. Psych and Mental Health Congress, November 8, 2011. Poster # 110.
Use of lisdexamfetamine dimesylate in treatment of cognitive impairment and fatigue (Chronic Fatigue Syndrome): A double-blind, placebo-controlled study, November 2011.
Primary Investigator: RCBM: Use of Lisdexamfetamine Dimesylate in the Treatment of Cognitive Impairment (Chronic Fatigue Syndrome): A Double-Blind, Placebo-Controlled Study, September 2009.
“AD/HD: Is There a Link to Fibromyalgia, Chronic Fatigue Syndrome, and Other Pain Issues?” Michael Golds Conference: Oakland Community College, Farmington Hills, MI, October 2006.
